CARMI, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 1.640
AS - Asia 1.168
EU - Europa 1.002
SA - Sud America 157
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 1
Totale 4.071
Nazione #
US - Stati Uniti d'America 1.585
SG - Singapore 400
CN - Cina 340
FI - Finlandia 205
VN - Vietnam 188
IT - Italia 167
SE - Svezia 144
IE - Irlanda 130
BR - Brasile 125
DE - Germania 124
UA - Ucraina 68
HK - Hong Kong 67
BD - Bangladesh 45
CA - Canada 40
ZA - Sudafrica 35
IN - India 31
TR - Turchia 30
NL - Olanda 29
FR - Francia 28
AT - Austria 26
CI - Costa d'Avorio 24
GB - Regno Unito 19
BE - Belgio 16
PL - Polonia 9
RU - Federazione Russa 9
CZ - Repubblica Ceca 8
IQ - Iraq 8
JP - Giappone 8
AR - Argentina 7
KR - Corea 7
MX - Messico 7
PK - Pakistan 7
CO - Colombia 5
VE - Venezuela 5
EC - Ecuador 4
ES - Italia 4
ID - Indonesia 4
IL - Israele 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
JO - Giordania 3
MY - Malesia 3
PH - Filippine 3
PY - Paraguay 3
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.038
Città #
Ashburn 226
Singapore 191
Chandler 161
Dallas 146
San Jose 140
Dublin 130
Santa Clara 103
Jacksonville 90
Beijing 83
Parma 80
Ann Arbor 68
Hong Kong 65
Ho Chi Minh City 58
Dearborn 54
Los Angeles 46
Boardman 40
New York 40
Hanoi 39
Shanghai 38
Munich 35
Council Bluffs 34
Johannesburg 33
Nanjing 31
Izmir 27
San Mateo 27
Vienna 25
Abidjan 24
Helsinki 24
Princeton 23
Lauterbourg 20
Toronto 20
Wilmington 17
Pune 16
Brussels 15
Buffalo 15
Hefei 15
Shenyang 14
São Paulo 14
Bremen 13
Kunming 12
Hebei 10
Nanchang 10
Columbus 9
Düsseldorf 9
Da Nang 8
Frankfurt am Main 8
Haiphong 8
Jinan 8
Montreal 8
Moscow 8
Tianjin 8
Milan 7
Prata Di Pordenone 7
Tokyo 7
Turku 7
Warsaw 7
Brno 6
Chicago 6
Denver 6
Phoenix 6
San Francisco 6
Stockholm 6
The Dalles 6
Des Moines 5
London 5
Ardea 4
Atlanta 4
Brooklyn 4
Changsha 4
Houston 4
Jakarta 4
Jiaxing 4
Manchester 4
Marseille 4
Montegaldella 4
Tashkent 4
Amsterdam 3
Baghdad 3
Bari 3
Belo Horizonte 3
Fremont 3
Fuzhou 3
Guangzhou 3
Lahore 3
Mexico City 3
Ottawa 3
Poplar 3
Rio de Janeiro 3
Rome 3
Seattle 3
São Vicente 3
Zhengzhou 3
Amman 2
Ankara 2
Aparecida de Goiânia 2
Aracaju 2
Augusta 2
Baku 2
Biên Hòa 2
Boa Vista 2
Totale 2.541
Nome #
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 281
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. 226
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 219
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 218
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 213
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 213
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 209
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 197
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability 193
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 183
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 180
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 169
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 161
Mannich base derivatives as novel EGFR irreversible inhibitors 155
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands 151
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion 150
Clinical perspective for irreversible tyrosine kinase inhibitors in cancer 149
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 147
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives. 145
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors 138
Irreversible EGFR inhibitor compounds with antiproliferative activity 135
Solution Phase Parallel Synthesis of S-DABO Analogues 84
Parallel Solution-Phase Synthesis of 1,5-disubstitued Hydantoins as New Protein Tyrosine Kinase Inhibitors 79
Parallel Solution-phase and Microwave-assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 76
Totale 4.071
Categoria #
all - tutte 12.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022129 0 0 5 7 7 2 22 23 7 13 10 33
2022/2023576 58 73 45 53 60 67 5 33 157 3 15 7
2023/2024192 12 11 1 5 12 60 22 14 5 9 14 27
2024/2025652 28 26 43 48 64 80 46 30 85 52 51 99
2025/20261.502 159 186 167 136 184 87 149 35 169 117 66 47
2026/2027112 32 78 2 0 0 0 0 0 0 0 0 0
Totale 4.071